As the Australian market navigates a soft week with the ASX200 down approximately 2%, local investors are looking to the bullish sentiment from Wall Street, which has recently set new record highs despite global geopolitical tensions. In this climate, identifying high growth tech stocks in Australia involves focusing on companies that demonstrate resilience and adaptability amidst fluctuating economic indicators and broader market sentiments.
Top 10 High Growth Tech Companies In Australia
| Name |
Revenue Growth |
Earnings Growth |
Growth Rating |
|---|---|---|---|
| Praemium |
8.36% |
20.04% |
★★★★★☆ |
| Cogstate |
14.92% |
24.46% |
★★★★★☆ |
| Kinatico |
14.08% |
64.43% |
★★★★☆☆ |
| Pureprofile |
11.50% |
36.43% |
★★★★☆☆ |
| Elsight |
48.48% |
51.39% |
★★★★★★ |
| Clinuvel Pharmaceuticals |
17.79% |
24.88% |
★★★★★☆ |
| BlinkLab |
56.69% |
63.59% |
★★★★★☆ |
| Oneview Healthcare |
26.22% |
70.90% |
★★★★★☆ |
| Xero |
16.48% |
21.32% |
★★★★☆☆ |
| Echo IQ |
121.33% |
108.72% |
★★★★★★ |
Click here to see the full list of 24 stocks from our ASX High Growth Tech and AI Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Cogstate
Simply Wall St Growth Rating:★★★★★☆
Overview:Cogstate Limited is a neuroscience solutions company focused on developing and commercializing digital brain health assessments globally, with a market cap of A$416.84 million.
Operations:The company generates revenue primarily from two segments: Healthcare, including sports, contributing $2.48 million, and Clinical Trials, which encompasses precision recruitment tools and research services, bringing in $53.59 million.
Cogstate, a player in the Australian tech scene, has demonstrated robust growth metrics that outpace many industry averages. With earnings expanding by 46.7% over the past year—significantly higher than the Healthcare Services industry's 17.7%—the company is making notable strides. This growth trajectory is bolstered by an expected annual earnings increase of 24.5%, positioning Cogstate well above the Australian market forecast of 12.1%. Additionally, recent corporate guidance highlighted a promising future with a projected revenue rise in the second half of fiscal year 2026 based on $21.7 million in contracted revenues, marking a substantial 24% increase from prior comparable periods. These figures not only reflect Cogstate's capacity to generate and increase revenue but also underscore its potential to sustain and possibly accelerate its growth momentum in upcoming years.
Data#3
Simply Wall St Growth Rating:★★★★☆☆
Overview:Data#3 Limited is an Australian company specializing in information technology solutions and services, with a market capitalization of A$1.24 billion.
Operations:Data#3 Limited generates revenue primarily through its Infrastructure Solutions and Services segments, contributing A$551.44 million and A$262.23 million respectively. The company also offers Software Solutions, adding A$70.74 million to its revenue stream.
Data#3, a tech firm in Australia, has shown promising growth with its recent financials indicating a revenue increase to AUD 423.08 million from AUD 391.32 million year-over-year and a net income rise to AUD 23.17 million. The company's strategic participation in multiple industry conferences across major Australian cities underscores its commitment to expanding its market presence. Despite an earnings growth forecast of 8.4% per year, slightly below the national average of 12.1%, Data#3 maintains a robust projected Return on Equity at an impressive 59%. This performance is complemented by positive free cash flow and quality earnings, positioning it for sustained operational success amidst competitive IT landscapes.
-
Click to explore a detailed breakdown of our findings in Data#3's health report.
-
Understand Data#3's track record by examining our Past report.
Nuix
Simply Wall St Growth Rating:★★★★☆☆
Overview:Nuix Limited offers investigative analytics and intelligence software solutions across various regions including the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market capitalization of approximately A$497.71 million.
Operations:Nuix Limited generates revenue primarily from its Software & Programming segment, amounting to A$237.49 million.
Nuix, an Australian tech entity, recently demonstrated a significant turnaround by posting a net income of AUD 11.08 million for the half-year ended December 31, 2025, contrasting sharply with a net loss of AUD 10.4 million in the prior year period. This recovery is underscored by a robust annual revenue growth forecast at 9%, outpacing the broader Australian market's growth rate of 6.4%. The firm's commitment to innovation is evident from its R&D expenses which are strategically aligned to propel future technologies and market expansion. Moreover, the recent board enhancements with seasoned executives like Rachel Barger and Ted Pretty are expected to strengthen Nuix's global strategic positioning and governance, fostering deeper market penetration especially in lucrative sectors such as enterprise software and AI infrastructure.
Next Steps
-
Dive into all 24 of the ASX High Growth Tech and AI Stocks we have identified here.
-
Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
-
Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Interested In Other Possibilities?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
-
Find companies with promising cash flow potential yet trading below their fair value .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:CGS ASX:DTL and ASX:NXL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
